A Perspective on Management of COPD Through the Lens of Comorbidities in the General and Elder Populations: Observations From the GOLDEN Studies
Friday, October 9, 2020 at 6:00pm Pacific (45 minutes)
- COPD Disease Burden in the General Population vs Nursing Homes and Long-term Care
- Phase III, GOLDEN studies on the efficacy and safety of Lonhala® Magnair®
- Post hoc analysis of primary data sets
Focus on Comorbidities
Clinically important deterioration
- eFlow® Closed System (eFlow® CS) nebulizer
- Health Economic Perspective
Register Now
Speaker:Shahin Sanjar PhDSenior Director, Medical AffairsSunovion Pharmaceuticals Inc. Sponsored by:
|